• Adams, H.R. (2001) Veterinary Pharmacology and Therapeutics. Iowa State Press, Ames, IA.
  • Akaike, H. (1974) Automatic control: a new look at the statistical model identification. IEEE Transactions on Automatic Control, 19, 716723.
  • Arndt, J.O., Mikat, M. & Parasher, C. (1984) Fentanyl’s analgesic, respiratory, and cardiovascular actions in relation to dose and plasma concentration in unanesthetized dogs. Anesthesiology, 61, 355361.
  • Freise, K.J., Newbound, G.C., Tudan, C. & Clark, T.P. (2012a) Pharmacokinetics and the effect of application site on a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles. Journal of Veterinary Pharmacology and Therapeutics, 35(Suppl. 2), 2733.
  • Freise, K.J., Savides, M.C., Riggs, K.L., Owens, J.G., Newbound, G.C. & Clark, T.P. (2012b) Pharmacokinetics and dose selection of a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles. Journal of Veterinary Pharmacology and Therapeutics, 35(Suppl. 2), 2126.
  • Hofmeister, E.H. & Egger, C.M. (2004) Transdermal fentanyl patches in small animals. Journal of the American Animal Hospital Association, 40, 468478.
  • Holm, S. (1979) A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6, 6570.
  • Holt, D.V., Viscusi, E.R. & Wordell, C.J. (2007) Extended-duration agents for perioperative pain management. Current Pain and Headache Reports, 11, 3337.
  • Moore, N.D. (2009) In search of an ideal analgesic of common acute pain. Acute Pain, 11, 129137.
  • Pace, N.L., Parrish, R.G., Lieberman, M.M., Wong, K.C. & Blatnick, R.A. (1979) Pharmacokinetics of naloxone and naltrexone in the dog. Journal of Pharmacology and Experimental Therapeutics, 208, 254256.
  • Paddleford, R.R. & Short, C.E. (1973) An evaluation of naloxone as a narcotic antagonist in the dog. Journal of the American Veterinary Medical Association, 163, 144146.
  • Pascoe, P.J. (2000) Opioid analgesics. The Veterinary Clinics of North America. Small Animal Practice, 30, 757772.
  • Plumb, D.C. (2002) Veterinary Drug Handbook. Iowa State Press, Ames, IA.
  • Savides, M.C., Pohland, R.C., Wilkie, D.A., Abbott, J.A., Newbound, G.C., Freise, K.J. & Clark, T.P. (2012) The margin of safety of a single application of transdermal fentanyl solution when administered at multiples of the therapeutic dose to laboratory dogs. Journal of Veterinary Pharmacology and Therapeutics, 35(Suppl. 2), 3543.
  • Smith, H.S. (2008) Combination opioid analgesics. Pain Physician, 11, 201214.
  • Smith, L.J., Krugner-Higby, L., Trepanier, L.A., Flaska, D.E., Joers, V. & Heath, T.D. (2004) Sedative effects and serum drug concentrations of oxymorphone and metabolites after subcutaneous administration of a liposome-encapsulated formulation in dogs. Journal of Veterinary Pharmacology and Therapeutics, 27, 369372.
  • Stanley, T.H. (1992) The history and development of the fentanyl series. Journal of Pain and Symptom Management, 7, S3S7.
  • Tao, P.L., Law, P.Y. & Loh, H.H. (2010) Search for the “ideal analgesic” in pain treatment by engineering the mu-opioid receptor. IUBMB Life, 62, 103111.
  • Urquhart, J. (2000) INTERNAL MEDICINE IN THE 21ST CENTURY: controlled drug delivery: therapeutic and pharmacological aspects. Journal of Internal Medicine, 248, 357376.
  • Veng-Pedersen, P., Wilhelm, J.A., Zakszewski, T.B., Osifchin, E. & Waters, S.J. (1995) Duration of opioid antagonism by nalmefene and naloxone in the dog: an integrated pharmacokinetic/pharmacodynamic comparison. Journal of Pharmaceutical Sciences, 84, 11011106.
  • Welch, J., Wohl, J. & Wright, J. (2002) Evaluation of postoperative respiratory function by serial blood gas analysis in dogs treated with transdermal fentanyl. Journal of Veterinary Emergency and Critical Care, 12, 8187.